Latest News

Growth and tech shares are leading the intraday slide as traders weigh a hotter-than-expected inflation report today, Nov. 10, 2026.

SpaceX is building multiple engines that could power the company's long-term growth.

Institutional clients ramp up as settlement rails reach 75 countries.

Academic weakness offset by China growth as a manufacturing overhaul nears.

Fox completed its $22 billion Roku acquisition on Nov. 6, following strong quarterly earnings from both companies, as investors now watch cost savings, streaming growth, and regulatory commitments.

Bitcoin and Ether should soar much higher over the next few years.

A debt-free balance sheet and proprietary software give Watsco structural advantages to expand beyond HVAC into plumbing and may compound market share.

It has stood the test of time and is built to continue doing so.

Management reaffirmed full-year guidance despite a temporary working capital squeeze.

USA Rare Earth almost reported a profit last night. So why aren't investors happier about that?

LENSAR (NASDAQ:LNSR) reported a slight decline in third-quarter revenue as lower sales of its cataract surgery systems offset growth in procedure and other recurring revenue. The company said its installed base and procedure volume continued to expand, while its operating loss narrowed from a year e

Regeneron Pharmaceuticals (NASDAQ:REGN) is advancing its experimental CIDEB therapy into later-stage studies for a form of liver disease after an early trial showed a single dose substantially reduced liver fat, executives said during an investor event. The company said its phase 2b study in patien

Jerash Holdings (US) (NASDAQ:JRSH) reported a 19.8% increase in fiscal second-quarter revenue and a more than fourfold rise in net income, as higher shipments to U.S. customers and efficiency gains helped offset elevated transportation costs. The Jordan-based apparel manufacturer said its productio

Lineage (NASDAQ:LINE) lowered its full-year adjusted EBITDA outlook after rising transportation costs and weaker-than-expected seasonal warehouse activity weighed on its third-quarter results. The cold-storage company maintained the midpoint of its adjusted funds from operations, or AFFO, per-share

Humacyte (NASDAQ:HUMA) reported third-quarter Symvess sales of approximately $1 million, up 151% from the preceding quarter, and said it expects sales to at least double again in the fourth quarter as more hospitals adopt the product. The company also plans to submit an application to the U.S. Food

Legend Biotech (NASDAQ:LEGN) reported 36% growth in third-quarter global net trade sales of its multiple myeloma treatment CARVYKTI, while executives said slower-than-anticipated gains in earlier-line U.S. patients and international launch delays could temper sales expectations. CARVYKTI sales reac

Terrestrial Energy (NASDAQ:IMSR) said its third-quarter cash burn rose as it advanced fuel development and testing, while outlining a natural gas bridge concept intended to supply power before its planned nuclear plants are completed. The company ended the quarter with $276.3 million in cash, cash

HIVE Digital Technologies (NASDAQ:HIVE) reported a wider fiscal second-quarter loss as lower Bitcoin mining economics prompted an equipment impairment, even as revenue and adjusted earnings improved from the preceding quarter and its artificial intelligence infrastructure business expanded. Revenue

Consolidated Water (NASDAQ:CWCO) reported lower third-quarter revenue and earnings as declines in construction, operations and maintenance, and manufacturing outweighed growth in its retail and bulk water businesses. Management pointed to a new California water reuse contract and a Florida equipment

Gilat Satellite Networks (NASDAQ:GILT) lowered its full-year revenue outlook after satellite launch delays, shifting customer delivery schedules and contract negotiations pushed some expected commercial business into 2027 and beyond. The company reported higher third-quarter profitability, however,

Brainsway (NASDAQ:BWAY) reported 34% revenue growth and a more than doubling of operating income in the third quarter of 2026, as shipments of its Deep TMS systems increased and reimbursement coverage expanded for its accelerated treatment protocol. The company expects full-year results to land at

Enbridge's pipeline toll-road model faces off against ExxonMobil's fortress balance sheet and global scale, with a valuation gap that may tip the scales.

Nvidia looks set to face multiple investigations at the federal level.

The eVTOL maker's results were a mixed bag.

While McDonald's has historically been a much safer stock than Wendy's in recent years, it's been the latter that's been picking up steam of late.